login
login
Image header Agence Europe
Europe Daily Bulletin No. 7812
Contents Publication in full By article 27 / 50
ECONOMIC INTERPENETRATION / (eu) medical material

The French EDAP TECHNOMED (turnover of FF 150 million forecasted for 2000) sold its "Prostatron" activity (benign prostrate tumour treatment) to the American UROLOGIX for USD 20 million.

Contents

THE DAY IN POLITICS
GENERAL NEWS
ECONOMIC INTERPENETRATION